Mumbai
Tier 1
$5,800 - $24,000
Robotic surgery, premium radiation, and advanced imaging raise the range.
Uro-oncology cost
Plan prostate cancer care with USD ranges for biopsy review, MRI, PSMA PET, robotic or open surgery, radiation, hormone therapy, and long-term monitoring.
How much does prostate cancer treatment cost in India?
Prostate cancer treatment in India commonly ranges from $4,000 to $24,000 depending on risk group, stage, robotic surgery, radiation technique, hormone therapy, PSMA PET, hospital city, and whether the case needs long-term systemic treatment. Low-risk localized disease can be very different from metastatic or recurrent prostate cancer.
City-wise cost
These ranges are planning bands. A hospital-backed quote should be requested after reports, diagnosis, and fitness details are reviewed.
Tier 1
$5,800 - $24,000
Robotic surgery, premium radiation, and advanced imaging raise the range.
Tier 1
$5,600 - $23,000
Useful for urology, radiation oncology, and medical oncology comparison.
Tier 1
$5,800 - $24,000
Often selected for robotic surgery and international patient workflows.
Tier 1
$5,300 - $22,000
Strong option for MRI-led planning and multi-specialty review.
Tier 1
$5,000 - $21,000
Established destination for urology, radiation, and oncology care.
Tier 1
$4,900 - $20,500
Can offer efficient packages when the treatment path is clear.
Major metro
$4,600 - $19,000
Practical for planned surgery or radiation after risk grouping.
Major metro
$4,500 - $18,500
Competitive for urology-led planned care and hormone therapy.
Major metro
$4,300 - $18,000
Useful for eastern-region patients comparing prostate cancer teams.
Tier 2
$4,000 - $16,500
Good for selected stable cases when urology and radiation backup are clear.
Tier 2
$4,000 - $16,000
Can reduce total trip cost for follow-up or hormone-based care.
Tier 2
$4,100 - $17,000
Confirm surgical volume, radiation access, and imaging requirements.
Tier choice
Robotic surgery, complex radiation, recurrent disease, or metastatic therapy may need Tier 1 depth.
Hormone therapy, follow-up, and selected surgery or radiation can work in Tier 2 cities with the right teams.
Continence, erectile function, urinary symptoms, and follow-up quality matter alongside cost.
Included
Quoted surgery, radiation, hormone therapy, or systemic treatment phase.
Prostate plans can be very different.
Urologist, uro-oncologist, radiation oncologist, or medical oncologist consultation.
Risk grouping decides the team.
Room, OT, radiation sessions, or day-care services as per the quoted plan.
Radiation is usually session based.
Basic labs, catheter care, nursing, and standard medicines when part of the package.
Ask about PSA follow-up.
Not included
PSMA PET, prostate MRI, bone scan, or repeat biopsy review if not bundled.
Can change stage and treatment.
Robotic prostatectomy may be quoted separately from open or laparoscopic surgery.
Technology choice affects cost.
ADT injections, newer hormonal drugs, or long-term systemic medicines.
These may continue for months or years.
Catheter issues, infection, incontinence care, stricture treatment, or extended stay.
Clarify post-op support.
Cost drivers
PSA, Gleason score, MRI, and stage decide low, intermediate, high, or metastatic risk.
Risk drives treatment.
Open, laparoscopic, and robotic prostatectomy have different package costs.
Ask what is included.
IMRT, IGRT, SBRT, brachytherapy, or conventional plans differ in session count and planning cost.
Technique matters.
Short-course or long-course ADT changes total cost beyond the first visit.
Long-term costs matter.
Advanced disease may require bone medicines, chemotherapy, newer tablets, or repeated scans.
Budget by phase.
Reports
The report checklist is different for each treatment so every cost page avoids generic duplicated content.
The estimate depends on risk category, urinary function, and spread assessment.
PSA trend and Gleason score help classify disease risk and urgency.
Shows local tumor extent, capsule involvement, seminal vesicle risk, and surgical planning details.
Used when spread is suspected or risk is high.
Flow symptoms, catheter history, heart risk, and medicine list affect surgery or radiation choice.
Hospital selection
Ask about prostate surgery volume, nerve-sparing approach, and complication management.
Experience affects recovery.
Confirm technique, fractions, image guidance, and expected side effects.
Session count affects stay.
Check prostate MRI, PSMA PET, pathology review, and biopsy-slide handling.
Useful before final plan.
Ask how PSA, urinary symptoms, hormone therapy, and local doctor handoff will be handled.
Prostate care continues after treatment.
Patient journey
Doctors classify prostate cancer using PSA, Gleason score, MRI, and staging scans.
Surgery, radiation, hormone therapy, surveillance, or systemic treatment is discussed.
Robotic surgery, radiation access, imaging, and total stay cost are compared by city.
Long-term PSA monitoring and local handoff are planned before returning home.
Recovery planning
Catheter removal, wound review, continence exercises, and pathology discussion should be planned.
Urinary irritation, bowel symptoms, fatigue, and session attendance need practical planning.
PSA monitoring schedule, hormone injections, and emergency symptoms should be documented.
Questions
Low-risk, high-risk, recurrent, and metastatic prostate cancer require different imaging, treatment, and follow-up.
Usually yes. Robotic surgery adds technology and OT cost, so it should be compared with open or laparoscopic options carefully.
Selected cases can be managed in Tier 2 cities if urology, radiation, imaging, and emergency support are appropriate.
PSA trend, biopsy with Gleason score, prostate MRI, PSMA PET or staging scans, urinary history, and medicine list are useful.
No. Depending on age, risk group, stage, and symptoms, options may include surveillance, surgery, radiation, hormone therapy, or systemic treatment.
It depends on technique and fraction schedule. Patients should ask how many sessions are planned before comparing city costs.
Only if the quote lists the hormone medicine or injection, dose, schedule, and duration.
Yes. Virello can compare risk group, technology, session count, city fit, inclusions, and follow-up requirements.